The pharmaceutical company Farmak has supplemented its portfolio with a new brand – hepatic medicine Hep-Art. The drug is available as a lyophilisate solution for injection.
The new product of Farmak – Hep-Art contains an active substance ademetionine.
Ademetionine deficiency plays a key role in the hepatopathy. Reduced ademetionine level deteriorates the liver condition leading to inflammation and further to irreversible structural and degenerative changes in the liver.* Hep-Art eliminates deficiency of the endogenous ademetionine and stimulates its production in the body.
According to the instructions, it is indicated to treat:
intrahepatic cholestasis in adults, including patients with chronic hepatitis of various etiologies and cirrhosis; intrahepatic cholestasis of pregnancy; depressive syndromes.
Olga Vereshchaka, Farmak Product Manager, "Hep-Art helps to restore the liver. Hep-Art acts as an antioxidant; it regenerates hepatic cells, and improves bile production and outflow. The triple action determines 7 effects of Hep-Art: choleretic, cholekinetic, antioxidant, detoxification, regeneration, neuroprotective,** antidepressant. Thus, we are able to treat patients with the intrahepatic cholestasis syndrome, getting improvement in their condition."
The drug is sold by prescription only.
The TOP 100 of the country’s most valued trademarks was presented by Novoe Vremya magazine in association with MPP Consulting. The cost of each brand was estimated by MPP Consulting. The valuation methodology is based on financial performance of brand owners, as well as factors that may influence the brand’s value, such as geographical coverage [&helli...
This edition is dedicated to Quality in all its manifestations and areas. In this edition, we discuss the following issues: How to protect oneself from drug falsification; • Where can one read about drug bioequivalence; • How are drugs disposed of; • How Farmak cares about the quality of its drugs. We remind that ‘Farmak […]
The purpose of the visit was to increase sustainability in the healthcare sector. On 15 November, Farmak welcomed the representatives of the government, non-governmental organizations, research institutes and UN system agencies within the framework of the Sustainable Procurement Workshop of the United Nations Development Programme. During the visit, the gues...